ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,868.40
      -0.79%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      86.965
      -0.29%
      Bitcoin
      64,137.69
      -0.22%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Jazz Pharmaceuticals PLC (JAZZ)

      7. Jazz Pharmaceuticals PLC (JAZZ) News

      JAZZ Jazz Pharmaceuticals PLC

      108.32
      -1.35 (-1.23%)
      Apr 24 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Jazz Pharmaceuticals PLC JAZZ NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -1.35 -1.23% 108.32 16:00:10
      Open Price Low Price High Price Close Price Prev Close
      108.66 107.60 109.39 108.32 109.67
      more quote information »

      Recent News

      Date Time Source Heading
      4/24/202416:05PRNUSJazz Pharmaceuticals to Present Data Across Growing Oncology..
      4/17/202416:15PRNUSJazz Pharmaceuticals to Report 2024 First Quarter Financial..
      4/10/202407:45PRNUSJazz Pharmaceuticals to Showcase Expansive Neuroscience..
      4/02/202407:30PRNUSJazz Pharmaceuticals Completes Zanidatamab Biologics License..
      3/12/202416:15PRNUSJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on..
      3/08/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202421:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202421:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202421:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202421:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202418:09EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202419:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202419:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
      3/01/202415:11EDGAR2Form 144 - Report of proposed sale of securities
      2/28/202416:06EDGAR2Form 8-K - Current report
      2/28/202416:05PRNUSJazz Pharmaceuticals Announces Full Year and Fourth Quarter..
      2/27/202407:45EDGAR2Form 8-K - Current report
      2/27/202407:45PRNUSJazz Pharmaceuticals Appoints Patrick Kennedy to its Board..
      2/21/202407:46EDGAR2Form 8-K - Current report
      2/21/202407:45PRNUSJazz Pharmaceuticals Appoints Philip Johnson as Chief..
      2/20/202416:15PRNUSJazz Pharmaceuticals to Participate in Upcoming March..
      2/14/202416:15PRNUSJazz Pharmaceuticals to Report 2023 Full Year and Fourth..
      2/07/202402:00PRNUSJazz Pharmaceuticals Enters Definitive Agreement with Redx..
      1/25/202417:01EDGAR2Form 8-K - Current report
      1/24/202409:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/19/202418:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202418:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202418:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202407:45EDGAR2Form 8-K - Current report
      12/21/202316:05PRNUSJazz Pharmaceuticals Provides Update on Phase 2 Trial of..
      12/20/202316:15PRNUSJazz Pharmaceuticals to Present at the 42nd Annual J.P...
      12/15/202307:45EDGAR2Form 8-K - Current report
      12/08/202313:20PRNUSJazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS..
      12/06/202316:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/06/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/01/202309:02PRNUSJazz Pharmaceuticals to Present Long-Term and Real-World..
      11/30/202307:45PRNUSJazz Pharmaceuticals to Present New Data Highlighting..
      11/14/202302:00BWAutifony Announces Exclusive Global License and..
      11/08/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/08/202316:07EDGAR2Form 8-K - Current report
      11/08/202316:05PRNUSJazz Pharmaceuticals Announces Third Quarter 2023 Financial..

      Your Recent History

      NASDAQ
      JAZZ
      Jazz Pharmaceuticals
      Delayed Upgrade Clock